Brief: Cinclus Pharma Proposes No Dividend
18/02/2026 07:16
Feb 18 (Reuters) - Cinclus Pharma Holding publ AB CINPHA.ST: Q4 NET SALES AMOUNTED TO TSEK 13,632 (4,580) Q4 OPERATING INCOME/LOSS (EBIT) AMOUNTED TO TSEK -62,011 (-56,889) BOARD PROPOSES THAT NO DIVIDEND WILL BE PAID FOR FINANCIAL YEAR Source text: ID:nMFNb5TXdg Further company coverage: CINPHA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))